Stock data
Indaptus Therapeutics, Inc. (INDP)
Indaptus Therapeutics, Inc. (INDP) reported net income of -US$20.85M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$19.83M | -US$20.85M | — |
| 2024 | — | — | -US$15.37M | -US$15.02M | — |
| 2023 | — | — | -US$16.38M | -US$15.42M | — |
| 2022 | — | — | -US$14.91M | -US$14.32M | — |
| 2021 | — | — | -US$7.73M | -US$7.71M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$1.79M | — |
| 2026-03-31 | — | -US$2.54M | — |
| 2025-12-31 | — | -US$8.11M | — |
| 2025-09-30 | — | -US$2.98M | — |
| 2025-06-30 | — | -US$5.23M | — |
| 2025-03-31 | — | -US$4.53M | — |
| 2024-12-31 | — | -US$4.13M | — |
| 2024-09-30 | — | -US$3.07M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.